Wellthy Therapeutics Raises $2.1 Million In Seed Funding

Mumbai-based Wellthy Therapeutics (Wellthy) recently announced it raised $2.1 million in seed funding. Funding participation included Dr. Ranjan Pai, Beenext Ventures, GrowX ventures, and Currae Healthcare, amongst others.

For the past two years, Wellthy has been conducting clinical pilots in order to gather real world evidence of its solution capability. Up until this round of seed funding, Wellthy’s effort have been all self-funded. The company anticipates using the funds to improve the efficacy of its type II diabetes digital therapeutic, as well as develop solutions for other diseases and expand its business further—particularly in the . . .